chloramphenicol has been researched along with Infections, Staphylococcal Skin in 5 studies
Amphenicol: Chloramphenicol and its derivatives.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Szumowski, JD | 1 |
Cohen, DE | 1 |
Kanaya, F | 1 |
Mayer, KH | 1 |
Hsu, CY | 1 |
Yang, SC | 1 |
Sung, CT | 1 |
Weng, YH | 1 |
Fang, JY | 1 |
Lykov, AP | 1 |
Gaidul, KV | 1 |
Goldina, IA | 1 |
Dushkin, AV | 1 |
BRANOM, WT | 1 |
HYMAN, AB | 1 |
RUBIN, Z | 1 |
NICOLAU, SG | 1 |
BADANOIU, A | 1 |
5 other studies available for chloramphenicol and Infections, Staphylococcal Skin
Article | Year |
---|---|
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Ma | 2007 |
Anti-MRSA malleable liposomes carrying chloramphenicol for ameliorating hair follicle targeting.
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Chloramphenicol; Deoxycholic Acid; Dimyri | 2017 |
[CLINICAL EFFICACY OF TREATMENT OF STAPHYLOCOCCAL INFECTION BY COMPOSITION OF NANOSTRUCTURED SILICON DIOXIDE AND FOSFOMYCIN.]
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Drug Compounding; Fosfomycin; Male; Nanoparticles; | 2017 |
Chancriform pyoderma.
Topics: Chloramphenicol; Diabetes Mellitus; Humans; Pyoderma; Skin Ulcer; Staphylococcal Infections; Staphyl | 1963 |
[OBSERVATIONS CONCERNING CERTAIN BACTERIOLOGICAL AND IMMUNOBIOLOGICAL ASPECTS OF CUTANEOUS STAPHYLOCOCCAL INFECTIONS. THERAPEUTIC DEDUCTIONS].
Topics: Chloramphenicol; Chlortetracycline; Dermatology; Drug Resistance; Drug Resistance, Microbial; Erythr | 1963 |